维普中文期刊产品整合服务
9篇 您的检索式:作者名="D. Tate"
    题名 作者 年代 出处 被引量
1The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study显示文摘Andrew D. Krahn Jure Manfreda Robert B. Tate Francis A.L. Mathewson T. Edward Cuddy 1995The American Journal of Medicine1995,,5:3
2COMPLEXITY OF SYSTEM MAINTAINABILITY ANALYSIS BASED ON THE INTERPRETIVE STRUCTURAL MODELING METHODOLOGY: TRANSDISCIPLINARY APPROACH显示文摘这篇论文构画出一条诊断途径确定一个广告的可维护性现成(简易窄床) 由分析系统部件的推广的复杂性基于系统。(主义) 说明结构的建模被用来表明主义怎么在在简易窄床部件之中识别并且理解互相依赖支持并且他们怎么影响 COTS 的维护的复杂性基于的系统(CBS ) 。通过主义分析,我们决定了在 CBS 的部件最显著地贡献哪个到系统的复杂性。与 ISM,建筑师,系统综合者,和系统一起,维护者们能孤立引起大多数复杂性的 COTS 产品,因此引起大多数努力维持,并且当必要时,采取措施仅仅改变那些产品或在主要维护努力期间。分析清楚地也显示出能容易在系统的其余部分上被很小的影响代替或升级的部件。A. Ertas M.W. Smith D. Tate W.D. Lawson T.B. Baturalp 2016Journal of Systems Science and Systems Engineering2016,25,2:2
3Elevated CO 2 and temperature effects on soil carbon and nitrogen cycling in ryegrass/white clover turves of an Endoaquept soil显示文摘D. J. Ross K. R. Tate P. C. D. Newton 1995Plant and Soil1995,,1:1
4Trends in Healthcare Utilization for Diarrhea and Rotavirus Disease in Privately Insured US Children <5 Years of Age, 2001–2006显示文摘Jennifer E. Cortes Aaron T. Curns Jacqueline E. Tate Umesh D. Parashar 2009The Pediatric Infectious Disease Journal2009,,10:1
5Soluble Host Defense Lectins in Innate Immunity to Influenza Virus显示文摘Wy Ching Ng Michelle D. Tate Andrew G. Brooks Patrick C. Reading Nobutaka Wakamiya 2012Journal of Biomedicine and Biotechnology2012,,:1
6Uptake and impact of Rotavirus vaccines in US Children显示文摘J. Cortes D. Esposito M. Cortese D. Bartlett J. Tate D. Payne M. Patel A. Curns J. Gentsch U. Parashar 2010International Journal of Infectious Diseases2010,,:1
7Linking on-farm dairy management practices to storm-flow fecal coliform loading for California coastal watersheds显示文摘D. J. Lewis E. R. Atwill M. S. Lennox L. Hou B. Karle K. W. Tate 2005Environmental Monitoring and Assessment (-)2005,,1:1
8患有斜视眼阵挛-肌阵挛综合征的儿童对ritux-imab的免疫和临床反应显示文摘Opsoclonus-myoclonus syndrome (OMS) is an autoimmune disorder with serious neurodevelopmental morbidity and limited treatment options. We treated a toddler with moderately severe OMS with rituximab, a monoclonal anti-B cell antibody. The patient’s clinical response was documented on videotape and scored with the OMS Evaluation Scale. Cerebrospinal fluid lymphocyte subsets were evaluated by flow-cytometric immunophenotyping, with a comprehensive panel of monoclonal antibodies. Eradication of cerebrospinal fluid B cells, which previously were expanded, was associated with dramatic clinical improvement. There also were secondary changes in other lymphocyte subsets that might be relevant to the clinical response and lack of serious infections. In addition to clarifying the immune response to B-cell depletion, these data reveal a promising new therapy for OMS that warrants a phase I clinical trial.PranzatelliM.R. Tate E.D. Travelstead A.L. Longee D. 王经纬 2006世界核心医学期刊文摘(儿科学分册)2006,2,5:0
9斜视眼阵挛-肌阵挛综合征患者的睡眠障碍和暴怒发作:对曲唑酮的反应显示文摘Objectives: Parents of children with opsoclonus-myoclonus syndrome (OMS) frequently describe poor sleep and rage attacks. We hypothesized that these manifestations are related and could result from underlying monoaminergic dysfunction. Study design: We clinically characterized the sleep and behavioral characteristics of 51 young children with OMS; 19 of those with the most disruptive sleep patterns were treated with trazodone, a soporific serotonergic agent. Results: Sleep disturbances, including prolonged sleep latency, fragmented sleep, reduced quantity of sleep, snoring, and nonrestorative sleep, were reported in 32 children, and frequent rage attacks were reported in 25. In 59% of the poor sleepers, parents felt that the problem was severe enough to warrant treatment. Children sleeping < 10 hours/night had a higher rage frequency than those who slept more. Of the children who required trazodone, 84% were receiving corticosteroids or adrenocorticotropic hormone (corticotrophin), compared with 37% in the subgroup with normal sleep. Trazodone (3.0 ± 0.4 mg/kg/day) improved sleep and behavior in 95% of the children, significantly increasing total sleep time by 72% , decreasing the number of awakenings by 76% , and reducing rage attacks by 33% . Conclusions: Children with OMS exhibited multiple types of sleep disturbances, which contributed to rage attacks. Trazodone was effective in improving sleep and decreasing rage attacks and was well tolerated, even in toddlers.Pranzatelli M. R. Tate E. D. Dukart W. S. 郭战宏(译) 2006世界核心医学期刊文摘(儿科学分册)2006,2,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费